There is a newer version of the record available.

Published May 2, 2023 | Version 1.0
Dataset Open

The BrainTeaser Ontology

Description

This repository contains the BrainTeaser Ontology (BTO) whose purpose is to jointly model both Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS).

BTO serves multiple purposes:

  • to provide a unified and comprehensive conceptual view about ALS and MS, which are typically dealt with separately, allowing us to coherently integrate the data coming from the different medical partners in the project;
  • to seamlessly represent both retrospective data and prospective data, produced during the lifetime of BRAINTEASER
  • to allow for sharing and re-using the BRAINTEASER datasets according to Open Science and FAIR principles.

BTO is innovative since it relies on very few seed concepts - Patient, Clinical Trial, Disease, Event - which allow us to jointly model ALS and MS and to grasp the time dimension entailed by the progression of such diseases.

Indeed, the core idea is that a Patient participates in a Clinical Trial, suffers from some Diseases, and undergoes Events. These Events are different in nature and cover a wide range of cases, e.g. Onset, Pregnancy, Symptom, Trauma, Diagnostic Procedure (like evoked potentials or ALS-FRS questionnaires) Therapeutic Procedure (like Mechanical Ventilation for ALS or Disease-Modifying Therapy for MS), Relapse, and more. Overall, this event-based approach allows us to model ALS and MS in an unified way, sharing concepts among these two diseases, and to track what happens during their progression. Details of the design and functioning of the BO are provided in the next sections of this deliverable.

The full BTO documentation can be accessed at https://brainteaser.dei.unipd.it/ontology/.

Files

Files (719.2 kB)

Name Size Download all
md5:1d527d082811d8cbc565ec365e6d9865
719.2 kB Download

Additional details

Funding

BRAINTEASER – BRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multiple SclERosis 101017598
European Commission